Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00127595
Status:
TERMINATED
Last Update Posted:
2005-08-24
First Post:
2005-08-05
Brief Title:
Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract
Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Organization:
Gustave Roussy Cancer Campus Grand Paris
Study Overview
Official Title:
A Phase II Monocentric Study of Oxaliplatin in Combination With Gemcitabine in Patients With AdvancedMetastatic Transitional Cell Carcinoma of the Urothelial Tract
Status:
TERMINATED
Status Verified Date:
2005-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a phase II monocentric study of oxaliplatin Ox in combination with gemcitabine Gem GEMOX in patients pts with advancedmetastatic transitional cell carcinoma TCC of the urothelial tract
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None